| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.6B | $7.7B | $6.7B | $6.2B | $1.6B | $1.5B | $1.4B | $1.2B |
| Cost of Revenue | — | — | — | — | — | — | $4.6B | $4.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.8B | $1.7B | $1.6B | $1.5B | $1.4B | $1.4B | $1.2B | $1.1B |
| Operating Income | $0.8B | $0.6B | $0.6B | $0.5B | $0.1B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.5B | $0.4B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $22.47 | $18.76 | $16.59 | $15.64 | $5.82 | $3.74 | $2.01 | $2.10 |
| EPS (Diluted) | $22.32 | $18.60 | $16.43 | $15.49 | $5.74 | $3.68 | $1.96 | $2.05 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.6B | $6.8B | $6.6B | $6.6B | $6.2B | $5.5B | $5.1B | $4.0B |
| Current Assets | $1.8B | $1.4B | $1.2B | $1.2B | $1.3B | $1.1B | $1.0B | $0.9B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $4.8B | $3.3B | $3.4B | $3.6B | $3.5B | $2.9B | $2.7B | $1.9B |
| Current Liabilities | $1.2B | $1.1B | $1.0B | $1.0B | $0.9B | $0.8B | $0.7B | $0.5B |
| Stockholders' Equity | — | $3.5B | $3.2B | $3.1B | $2.7B | $2.7B | $2.4B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.4B | $0.7B | $0.6B | $0.5B | $0.6B | $0.3B |
| Investing Cash Flow | $-1.8B | $-0.2B | $-0.1B | $-0.7B | $-0.4B | $-0.2B | $-1.1B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $1.2B | $-0.3B | $-0.3B | $-0.0B | $-0.2B | $-0.3B | $0.6B | $-0.2B |